日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chemotherapy alters radiosensitivity and GRPR expression of prostate and breast cancer cells

化疗会改变前列腺癌和乳腺癌细胞的放射敏感性和GRPR表达。

Damiana, Tyrillshall S T; van den Brink, Lilian; de Kreij-de Bruin, Lisette W; Stuurman, Debra C; de Ridder, Corrina M A; Dalm, Simone U

In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions.

eFAP 的体外和体内分析:一种新型的 FAP 靶向小分子,用于放射性核素治疗诊断和其他肿瘤干预

van der Heide Circe D, Ma Hanyue, Hoorens Mark W H, Campeiro Joana D, Stuurman Debra C, de Ridder Corrina M A, Seimbille Yann, Dalm Simone U

In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib.

利用奥拉帕尼进行肽受体放射性核素治疗放射增敏的体内疗效试验

Feijtel Danny, Reuvers Thom G A, van Tuyll-van Serooskerken Christine, de Ridder Corrina M A, Stuurman Debra C, de Blois Erik, Verkaik Nicole S, de Bruijn Peter, Koolen Stijn L W, de Jong Marion, Nonnekens Julie

Safety of [(177)Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity

[(177)Lu]Lu-NeoB 治疗的安全性:一项表征吸收剂量及急性、早期和晚期器官毒性的临床前研究

Ruigrok, Eline A M; Verhoeven, Marjolein; Konijnenberg, Mark W; de Blois, Erik; de Ridder, Corrina M A; Stuurman, Debra C; Bertarione, Luisa; Rolfo, Katia; de Jong, Marion; Dalm, Simone U

In Vivo Evaluation of Indium-111-Labeled 800CW as a Necrosis-Avid Contrast Agent

体内评价铟-111标记的800CW作为坏死亲和性造影剂

Stroet, Marcus C M; de Blois, Erik; Stuurman, Debra C; de Ridder, Corrina M A; Haeck, Joost; Seimbille, Yann; Mezzanotte, Laura; de Jong, Marion; Löwik, Clemens W G M; Panth, Kranthi M